PTAB

IPR2017-01526

Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH

General

Filed

06/05/17

Institution12/13/17

FWD--

Close12/12/18

StatusFinal Written Decision

OutcomeUnpatentable

Appeals

Administrative Patent Judges

Judge	Cases	Inst. Rate	FWD Inv. Rate
Erica A Franklin	400+	56%	68%
Michelle N Ankenbrand	200+	50%	81%
Roberta Pollock	400+	70%	68%

Petitioner

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A

No Parties

Attorney

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 B
Richard Torczon	L5 A
Jeffrey Guise	L3 B
Nicole W. Stafford	-- -- --
Lorelei Westin	-- -- --
Clark Lin	-- -- --
Alina Litoshyk	-- -- --

No Attorneys

Respondent

Party

Name	Ratings
Sanofi-Aventis Deutschland GmbH	L3 B

No Parties

Attorney

No Attorneys